Duquesne Family Office LLCDuquesne Family Office LLC

Institutional investor · Portfolio as of Q1 2025

Top Holdings52 positions

Checking export access…
Activity:

NATERA INC

3.4M$481.1M15.7%$96.17+47.04%
11 qtrssince 2022-Q3
Decreased
0
TEVATEVA
ADR

TEVA PHARMACEUTICAL INDS LTD

14.9M$228.7M7.5%$19.02-19.18%
3 qtrssince 2024-Q3
Increased
88

COUPANG INC CL A

9.3M$204M6.7%$34.12-35.72%
17 qtrssince 2021-Q1
Increased
63

WOODWARD INC

1.1M$200.3M6.5%$149.59+21.25%
6 qtrssince 2023-Q4
Decreased
0

Philip Morris International Inc.

1.1M$175.4M5.7%$102.51+47.49%
4 qtrssince 2024-Q2
Decreased
0

Coherent Corp

2.2M$144.3M4.7%$64.13+2.49%
5 qtrssince 2024-Q1
Decreased
0

Mercadolibre Inc

53,725$104.8M3.4%$1,737.70+12.27%
4 qtrssince 2024-Q2
Unchanged
0

INSMED INC

1.4M$104.4M3.4%$73.12+4.34%
4 qtrssince 2024-Q2
Increased
90
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MFG LTD

598,780$99.4M3.2%$166.29-1.89%
3 qtrssince 2024-Q3
Increased
90

DOCUSIGN INC

1.1M$87.5M2.9%$83.180.00%
1 qtr
New
78

FLUTTER ENTMT PLC SHS

377,475$83.6M2.7%$226.59+0.98%
4 qtrssince 2024-Q2
Increased
83

Eli Lilly & Co.

94,830$78.3M2.6%$781.41+4.59%
2 qtrssince 2024-Q4
Increased
72
YPFYPF
ADR

YPF SOCIEDAD ANONIMA

2.1M$72.7M2.4%$36.57-1.56%
4 qtrssince 2024-Q2
Increased
63
VRNAVRNADelisted
ADR

VERONA PHARMA PLC

1M$63.6M2.1%——
3 qtrssince 2024-Q3
Increased
58
BCSBCS
ADR

BARCLAYS PLC

3.8M$58.6M1.9%$11.62+31.42%
5 qtrssince 2024-Q1
Increased
56

WABTEC

301,095$54.6M1.8%$164.63+9.37%
5 qtrssince 2024-Q1
Increased
51

CCC INTELLIGENT SOLUTIONS HLD COM

5.6M$50.5M1.7%$8.920.00%
1 qtr
New
68

KINDER MORGAN INC DEL

1.7M$47.2M1.5%$17.42+56.14%
5 qtrssince 2024-Q1
Decreased
0

EQT Corporation

859,345$45.9M1.5%$52.540.00%
1 qtr
New
68
DALDAL
CALL

DELTA AIR LINES INC DEL

949,500$41.4M1.4%———
Unchanged
—
$3.1B
AUM
52
Positions
Q1 2025
Filing
HI score · 1.5/5
Quarterly 13F Value Change
+12%Q4'23$3.1B+20%Q1'24$3.7B-24%Q2'24$2.8B+1%Q3'24$2.9B+25%Q4'24$3.6B-16%Q1'25$3B
Activity profile
$ moved · Q1'25
New18%Increased17%Decreased29%Exited36%
Composition
Equity vs derivatives
Equity97%Puts0%Calls3%
Holding period
Avg 2.0 years
<1Q12%1-4Q33%1-2Y21%2Y+35%

Duquesne Family Office LLC manages $3.1B across 52 positions as of Q1 2025. Top holdings: NTRA (15.7%), TEVA (7.5%), CPNG (6.7%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.

Q1 2025 Summary

Active quarter - 12 new positions, 37 exits, 14 increased. Top move: INSM (INCREASED, conviction 90). Portfolio: $3.1B across 52 positions.

Top holdings by portfolio weight

Total AUM$3B
NTRA15.72%
TEVA7.47%
CPNG6.67%
WWD6.55%
PM5.73%
COHR4.72%
MELI3.43%
INSM3.41%
TSM3.25%
DOCU2.86%
Other2.73%

Portfolio allocation by GICS sector

Sectors10
Healthcare31.93%
Technology16.58%
Consumer Cyclical15.49%
Industrials10.74%
Energy6.28%
Consumer Defensive5.88%
Financial Services5.50%
Unknown4.25%
Basic Materials1.82%
Communication Services1.52%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare, Technology, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L41
Conviction47
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
ADMAADMAADMA BIOLOGICS INC
Q1 2026 → Q2 2026+2.5M shares+$18.7M
2Q
CLFCLFCLEVELAND-CLIFFS INC NEW
Q1 2026 → Q2 2026+2.5M shares+$16.4M
2Q
NTRANTRANATERA INC
Q1 2026 → Q2 2026+674,949 shares+$289.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used